Zynex (ZYXI)
(Delayed Data from NSDQ)
$1.27 USD
-0.97 (-43.27%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.28 +0.02 (1.19%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZYXI 1.27 -0.97(-43.27%)
Will ZYXI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZYXI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZYXI
Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
Zynex Inc. (ZYXI) Reports Q1 Loss, Lags Revenue Estimates
ZYXI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates
ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial
Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates
Other News for ZYXI
12 Health Care Stocks Moving In Friday's Intraday Session
Zynex (ZYXI) Upgraded to Buy Amid New Product Potential
Zynex (ZYXI) Upgraded to 'Buy' with New Price Target
Ladenburg upgrades Zynex, says NiCO opportunity 'should not be overlooked'
12 Health Care Stocks Moving In Friday's Pre-Market Session